#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Niemann-Pick disease Acute hepatic failure Endometrial adenocarcinoma Subdural haematoma Thermal burn Muscular dystrophy Neonatal asphyxia Obliterative bronchiolitis Encephalitis autoimmune Juvenile psoriatic arthritis Osteochondrodysplasia Fallopian tube cancer Chronic graft versus host disease in skin Ataxia telangiectasia Immune-mediated myasthenia gravis More trials…

    Learn about Rare Diseases

    Proteus syndrome – Trials in Disease Small intestine leiomyosarcoma Haemolytic uraemic syndrome – Life with Disease Marfan’s syndrome – Diagnostics Primary hyperoxaluria – Diagnostics Haemophilia B with anti factor IX – Trials in Disease Optic glioma – Treatment CADASIL – Basic Information Ewing’s sarcoma – Trials in Disease Isodicentric chromosome 15 syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Histamine Dihydrochloride Oregovomab Glibenclamide Onasemnogene Abeparvovec Dantrolene Sodium Disodium Levofolinate Ng004 Moxifloxacin Silibinin Naxitamab Etamsylate Gsk3858279 7-Ethyl-10-Hydroxycamptothecin Metoprolol Tartrate Zilovertamab Vedotin Mk-0482 Alitretinoin At-1501 Azd3470 Methylprednisolone Aceponate More therapies…

    Learn about Your Condition

    Vestibular disorder Mesothelioma malignant Inguinal hernia Gastrointestinal carcinoma Exposure via breast milk Ankylosing spondylitis BRAF gene mutation Polycythaemia vera Endometrial cancer metastatic Trisomy 21 Hypothyroidism Oropharyngeal cancer recurrent Nephrotic syndrome Cardiac failure acute Actinic keratosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Clinique Victor Hugo

Clinique Victor Hugo

Centre De Cancerologie De La Sarthe, 64 Rue De Degre, Le Mans, 72000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Bladder cancer
    • Bladder cancer stage II
    • Bladder cancer stage III
    Investigated Drugs:
    • Cisplatin
    • Gemcitabine
    • Pembrolizumab
    Belgium Denmark France Germany Hungary Ireland +4

  • Study of Radiotherapy with Cetuximab and Xevinapant for Patients with Advanced Head and Neck Cancer Unfit for High-Dose Cisplatin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Cetuximab
    • Xevinapant
    France

  • Comparison of drug combinations containing irinotecan, oxaliplatin, fluorouracil and folinic acid for treatment of high-risk stage III colon cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan
    France Italy

  • Study on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Renal cancer metastatic
    Investigated Drugs:
    • Cabozantinib
    • Ipilimumab
    • Nivolumab
    Belgium Czechia Finland France Germany Italy +3

  • Study Comparing Tivozanib and Nivolumab Combination to Tivozanib Alone in Patients with Renal Cell Carcinoma After Previous Immune Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Nivolumab
    • Tivozanib
    Belgium Czechia France Germany Italy Poland +2

  • Study on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Enzalutamide
    • Talazoparib
    Belgium Czechia Finland France Germany Hungary +6

  • Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Pembrolizumab
    • Petosemtamab
    Austria Belgium Croatia Czechia France Germany +8
Previous Page
1 … 7 8 9

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!